Home

Spoštljiva klerikal Mordrin alpha synuclein Svetloba uganka Medic

Iron-mediated interaction of alpha synuclein with lipid raft model  membranes - Nanoscale (RSC Publishing)
Iron-mediated interaction of alpha synuclein with lipid raft model membranes - Nanoscale (RSC Publishing)

The Cellular Environment Affects Monomeric α-Synuclein Structure: Trends in  Biochemical Sciences
The Cellular Environment Affects Monomeric α-Synuclein Structure: Trends in Biochemical Sciences

Frontiers | Lipids at the Crossroad of α-Synuclein Function and  Dysfunction: Biological and Pathological Implications
Frontiers | Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications

Frontiers | Alpha-Synuclein Induced Immune Cells Activation and Associated  Therapy in Parkinson's Disease
Frontiers | Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease

Experimental Neurobiology
Experimental Neurobiology

Frontiers | The Role of Lipids in the Initiation of α-Synuclein Misfolding
Frontiers | The Role of Lipids in the Initiation of α-Synuclein Misfolding

New Role for α-Synuclein: Stabilizing mRNA in P-Bodies | ALZFORUM
New Role for α-Synuclein: Stabilizing mRNA in P-Bodies | ALZFORUM

Modulating membrane binding of α-synuclein as a therapeutic strategy | PNAS
Modulating membrane binding of α-synuclein as a therapeutic strategy | PNAS

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic  strategies | Nature Medicine
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies | Nature Medicine

Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease

活性型 α-シヌクレイン・タンパク質 | アブカム
活性型 α-シヌクレイン・タンパク質 | アブカム

A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease
A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease

Pathological α-synuclein transmission initiated by binding  lymphocyte-activation gene 3 | Science
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 | Science

Parkinson's disease biomarkers based on α‐synuclein - Fayyad - 2019 -  Journal of Neurochemistry - Wiley Online Library
Parkinson's disease biomarkers based on α‐synuclein - Fayyad - 2019 - Journal of Neurochemistry - Wiley Online Library

Zeroing in on neurodegenerative α-synuclein | Nature Reviews Drug Discovery
Zeroing in on neurodegenerative α-synuclein | Nature Reviews Drug Discovery

Alpha-synuclein at the intracellular and the extracellular side: functional  and dysfunctional implications
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications

α-Synuclein Aggregates Increase the Conductance of Substantia Nigra  Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor  Glibenclamide | eNeuro
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro

Interactions between iron and α-synuclein pathology in Parkinson's disease  - ScienceDirect
Interactions between iron and α-synuclein pathology in Parkinson's disease - ScienceDirect

Webinar: "Primary Parkinson's Protein Alpha-synuclein" November 2016 -  YouTube
Webinar: "Primary Parkinson's Protein Alpha-synuclein" November 2016 - YouTube

alpha-Synuclein-based Model for Studying Parkinsons Disease Pathology: R&D  Systems
alpha-Synuclein-based Model for Studying Parkinsons Disease Pathology: R&D Systems

Alpha-synuclein - Wikipedia
Alpha-synuclein - Wikipedia

Structural features of the alpha-synuclein monomer. A structure of the... |  Download Scientific Diagram
Structural features of the alpha-synuclein monomer. A structure of the... | Download Scientific Diagram

Role of Alpha-Synuclein Proteins in Disease
Role of Alpha-Synuclein Proteins in Disease

Alpha Synuclein – The Science of Parkinson's
Alpha Synuclein – The Science of Parkinson's